Clinical Trial Update: An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD [Phase 3]

View source ↗

Summary

An extension Phase 3 trial assessing the efficacy and safety of BCD-132 in multiple sclerosis patients who previously received Biocad-sponsored therapy has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• BCD-132 (BCD-132)

Snippet

Sponsor: Biocad | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED